NRx Pharmaceuticals, Inc. (NRXP)
NASDAQ: NRXP · Real-Time Price · USD
1.200
-0.010 (-0.83%)
Nov 21, 2024, 12:44 PM EST - Market open
NRXP's stock price has decreased by -60.88% in the past year and price targets may not have had time to catch up.
NRx Pharmaceuticals Analyst Ratings
Total Analysts
3
Consensus Rating
Strong Buy
Price Target
$31.33
Upside
+2,510.83%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
EF Hutton | EF Hutton | Strong Buy Maintains $31 | Strong Buy | Maintains | $31 | +2,483.33% | Oct 30, 2024 |
EF Hutton | EF Hutton | Strong Buy Initiates $31 | Strong Buy | Initiates | $31 | +2,483.33% | Oct 21, 2024 |
Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $43 → $44 | Strong Buy | Maintains | $43 → $44 | +3,566.67% | Sep 12, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $2 → $19 | Strong Buy | Maintains | $2 → $19 | +1,483.33% | Aug 5, 2024 |
Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $50 → $43 | Strong Buy | Maintains | $50 → $43 | +3,483.33% | Jun 7, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +1,566.67% | May 25, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +1,566.67% | Feb 2, 2023 |
Ascendiant Capital | Ascendiant Capital | Strong Buy Initiates $40 | Strong Buy | Initiates | $40 | +3,233.33% | Nov 9, 2022 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $20 | Strong Buy | Initiates | $20 | +1,566.67% | Jun 30, 2022 |